210 related articles for article (PubMed ID: 11553398)
1. The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy.
Griffin CE; Hillier A
Vet Immunol Immunopathol; 2001 Sep; 81(3-4):363-83. PubMed ID: 11553398
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases.
Fennis EEM; van Damme CMM; Schlotter YM; Sinke JD; Leistra MHG; Bartels RT; Broere F
Vet Dermatol; 2022 Aug; 33(4):321-e75. PubMed ID: 35635279
[TBL] [Abstract][Full Text] [Related]
3. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study.
Mueller RS; Veir J; Fieseler KV; Dow SW
Vet Dermatol; 2005 Feb; 16(1):61-8. PubMed ID: 15725107
[TBL] [Abstract][Full Text] [Related]
4. Requirement for additional treatment for dogs with atopic dermatitis undergoing allergen-specific immunotherapy.
Colombo S; Hill PB; Shaw DJ; Thoday KL
Vet Rec; 2007 Jun; 160(25):861-4. PubMed ID: 17586789
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy.
Keppel KE; Campbell KL; Zuckermann FA; Greeley EA; Schaeffer DJ; Husmann RJ
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):337-44. PubMed ID: 18423890
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of low dose immunotherapy in the treatment of canine atopic dermatitis: a prospective, double-blinded, clinical study.
Colombo S; Hill PB; Shaw DJ; Thoday KL
Vet Dermatol; 2005 Jun; 16(3):162-70. PubMed ID: 15960629
[TBL] [Abstract][Full Text] [Related]
7. The future of immunotherapy for canine atopic dermatitis: a review.
DeBoer DJ
Vet Dermatol; 2017 Feb; 28(1):25-e6. PubMed ID: 28133873
[TBL] [Abstract][Full Text] [Related]
8. Allergen-specific immunotherapy in dogs with atopic dermatitis: is owner compliance the main success-limiting factor?
Ramió-Lluch L; Brazís P; Ferrer L; Puigdemont A
Vet Rec; 2020 Dec; 187(12):493. PubMed ID: 33082241
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of intralymphatic immunotherapy (ILIT) on canine atopic dermatitis.
Timm K; Mueller RS; Nett-Mettler CS
Vet Dermatol; 2018 Apr; 29(2):123-e49. PubMed ID: 29327474
[TBL] [Abstract][Full Text] [Related]
10. A survey of primary care practitioners' referral habits and recommendations of allergen-specific immunotherapy for canine and feline patients with atopic dermatitis.
Flanagan S; Schick A; Lewis TP; Chu Tater K; Rishniw M
Vet Dermatol; 2021 Apr; 32(2):106-e21. PubMed ID: 33275300
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of regionally-specific immunotherapy for the management of canine atopic dermatitis.
Plant JD; Neradilek MB
BMC Vet Res; 2017 Jan; 13(1):4. PubMed ID: 28056956
[TBL] [Abstract][Full Text] [Related]
12. The ACVD task force on canine atopic dermatitis (VI): IgE-induced immediate and late-phase reactions, two inflammatory sequences at sites of intradermal allergen injections.
Hill PB; Hillier A; Olivry T
Vet Immunol Immunopathol; 2001 Sep; 81(3-4):199-204. PubMed ID: 11553380
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy for the long-term control of dogs with nonseasonal atopic dermatitis.
Fischer NM; Rostaher A; Favrot C
Vet Dermatol; 2020 Oct; 31(5):365-e96. PubMed ID: 32537789
[TBL] [Abstract][Full Text] [Related]
14. Rush allergen specific immunotherapy protocol in feline atopic dermatitis: a pilot study of four cats.
Trimmer AM; Griffin CE; Boord MJ; Rosenkrantz WS
Vet Dermatol; 2005 Oct; 16(5):324-9. PubMed ID: 16238812
[TBL] [Abstract][Full Text] [Related]
15. The ACVD task force on canine atopic dermatitis (IX): the controversy surrounding the route of allergen challenge in canine atopic dermatitis.
Olivry T; Hill PB
Vet Immunol Immunopathol; 2001 Sep; 81(3-4):219-25. PubMed ID: 11553383
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the safety of an abbreviated course of injections of allergen extracts (rush immunotherapy) for the treatment of dogs with atopic dermatitis.
Mueller RS; Bettenay SV
Am J Vet Res; 2001 Mar; 62(3):307-10. PubMed ID: 11277192
[TBL] [Abstract][Full Text] [Related]
17. Effect of hyposensitization on atopic dermatitis in dogs.
Willemse A; Van den Brom WE; Rijnberk A
J Am Vet Med Assoc; 1984 May; 184(10):1277-80. PubMed ID: 6376442
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal evaluation of immunological responses to allergen-specific immunotherapy in horses with IgE associated dermatological disease, a pilot study.
Radwanski NE; Morris DO; Boston RC; Cerundolo R; Lee KW
Vet Dermatol; 2019 Jun; 30(3):255-e78. PubMed ID: 30828914
[TBL] [Abstract][Full Text] [Related]
19. Determination of the efficacy rate and time-to-efficacy of subcutaneous immunotherapy in dogs with atopic dermatitis.
Tham HL; Olivry T
Vet Dermatol; 2022 Apr; 33(2):155-e44. PubMed ID: 34883529
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 10 and transforming growth factor-beta 1 plasma levels in atopic dogs before and during immunotherapy.
Martini F; Rostaher A; Favrot C; Fischer N
Vet Rec; 2022 Jun; 190(12):e1270. PubMed ID: 34939678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
